Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Sr. VP, Gen Counsel, and Sec. | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 35,259 |
Reported balance
After 2026-06-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-15 · Sale · Disposed 1,419 · Balance 35,259 F1: As of June 15, 2026, 8,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: As of June 15, 2026, 8,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,453 on June 2, 2027; 1,252 on June 3, 2027; 1,376 on June 4, 2027; 1,453 on June 2, 2028; 1,252 on June 5, 2028 and 1,453 on June 4, 2029.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 30,796 · Balance 0 F1: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.34 · Expires 2023-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,000 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 12,252 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 12,252 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 8,000 · Balance 0 F5: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F6: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 14,000 · Balance 0 F7: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 21,536 · Balance 0 F8: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 21,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 12,252 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 21,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2020 Filed Sep 15, 2020 20:34 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,000 | $167.00 | $334,000.00 |
DisclosureSEC source: 0001209191-20-050468 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,884 F1 · shares: This sale of a total of 2,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F2 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:05 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 18,168 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001209191-20-034115 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,168 Underlying: Ordinary Shares · 18,168 shares Expires 2030-06-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 4,542 on June 1, 2021; 4,542 on June 1, 2022; 4,542 on June 1, 2023 and 4,542 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:05 UTC | STERIS plc STE · Entity 3228 | Disposition to issuerOrdinary Shares | 771 | $165.65 | $127,716.15 |
DisclosureSEC source: 0001209191-20-034115 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,884 F2 · shares: 771 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 771 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 ordinary shares were awarded to Mr. Zangerle on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. F3 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:05 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034115 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,655 F1 · shares: All 3,008 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,504 on June 1, 2022; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-20-009212 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 Old STERIS ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 3,000 | $162.00 | $486,000.00 |
DisclosureSEC source: 0001209191-20-009212 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,647 F2 · shares: This exercise of stock options and sale of a total of 3,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 14, 2019. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022 and 834 on May 31, 2023. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 3,000 | $45.34 | $136,020.00 |
DisclosureSEC source: 0001209191-20-009212 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022 and 834 on May 31, 2023. Read SEC document |
| October 04, 2019 Filed Oct 7, 2019 20:30 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,000 | $142.15 | $142,150.00 |
DisclosureSEC source: 0001209191-19-052666 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,647 F1 · shares: This sale of a total of 1,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 8, 2019. F2 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022 and 834 on May 31, 2023. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:41 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 2,041 | $140.62 | $287,005.42 |
DisclosureSEC source: 0001209191-19-051746 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,647 F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022 and 834 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 19,244 | Not disclosed Strike: $147.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-033953 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,244 Underlying: Ordinary Shares · 19,244 shares Expires 2029-05-31 F4 · price: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023. F4 · derivative.exercise_date: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,500 | $131.77 | $197,655.00 |
DisclosureSEC source: 0001209191-19-033953 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,688 F3 · shares: This sale of a total of 1,500 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 16, 2019. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:44 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 3,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033953 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,188 F1 · shares: All 3,336 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,502 on May 31, 2022 and 834 on May 31, 2023. F2 · balance_after: 19,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022 and 834 on May 31, 2023. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:40 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 944 | $133.92 | $126,420.48 |
DisclosureSEC source: 0001209191-19-033446 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,852 F1 · shares: 944 shares were withheld from the 3,000 restricted shares that vested on May 28, 2019. These 944 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,000 ordinary shares were awarded to Mr. Zangerle on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019. F2 · balance_after: 16,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 21,536 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 7 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,536 Underlying: Ordinary Shares · 21,536 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 21,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 21,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 14,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 6 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Ordinary Shares · 14,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 14,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 14,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 5 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 8,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 4 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 F5 · price: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 12,252 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,252 Underlying: Ordinary Shares · 12,252 shares Expires 2024-05-30 F4 · price: This option to purchase 12,252 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 12,252 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F4 · derivative.exercise_date: This option to purchase 12,252 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 12,252 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $45.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 3,000 shares Expires 2023-05-31 F3 · price: This option to purchase 3,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. F3 · derivative.exercise_date: This option to purchase 3,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:50 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 30,796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021616 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,796 F1 · shares: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 21,536 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · derivative · entry 7 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 21,536 shares Expires 2028-05-31 F8 · price: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 21,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 21,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 14,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · derivative · entry 6 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,000 shares Expires 2027-05-30 F7 · price: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 14,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · derivative · entry 5 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F6 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 8,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · derivative · entry 4 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 F5 · price: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 12,252 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,252 shares Expires 2024-05-30 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 12,252 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 12,252 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $45.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,000 shares Expires 2023-05-31 F3 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. F3 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 14:23 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 30,796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021572 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| January 25, 2019 Filed Jan 28, 2019 21:35 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001209191-19-005538 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 6,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 6,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 6,000 STERIS common shares for $45.34 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| January 25, 2019 Filed Jan 28, 2019 21:35 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 3,000 | $115.00 | $345,000.00 |
DisclosureSEC source: 0001209191-19-005538 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,796 F2 · balance_after: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. Read SEC document |
| January 25, 2019 Filed Jan 28, 2019 21:35 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 3,000 | $45.34 | $136,020.00 |
DisclosureSEC source: 0001209191-19-005538 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 3,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 9, 2018. Read SEC document |
| January 11, 2019 Filed Jan 14, 2019 21:41 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0001209191-19-003563 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,750 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,500 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,500 STERIS common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| January 11, 2019 Filed Jan 14, 2019 21:41 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 1,750 | $110.00 | $192,500.00 |
DisclosureSEC source: 0001209191-19-003563 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,796 F2 · balance_after: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. Read SEC document |
| January 11, 2019 Filed Jan 14, 2019 21:41 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 1,750 | $36.09 | $63,157.50 |
DisclosureSEC source: 0001209191-19-003563 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 1,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 9, 2018. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:56 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 21,536 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-18-034747 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,536 Underlying: Ordinary Shares · 21,536 shares Expires 2028-05-31 F4 · derivative.exercise_date: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 20:56 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 3,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034747 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,796 F2 · shares: All 3,636 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 3,636 on May 31, 2022. F3 · balance_after: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:56 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 686 | $104.57 | $71,735.02 |
DisclosureSEC source: 0001209191-18-034747 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,160 F1 · shares: 686 shares were withheld from the 2,252 restricted shares that vested on May 30, 2018. These 686 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,252 shares were awarded to Mr. Zangerle on May 30, 2014 as part of an award of 2,252 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2018. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:40 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,900 | $0.00 Strike: $29.94 | $0.00 |
DisclosureSEC source: 0001209191-17-060914 · doc4.xml · derivative · entry 6 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,900 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 3,800 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,800 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:40 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0001209191-17-060914 · doc4.xml · derivative · entry 5 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Ordinary Shares · 3,500 shares Expires 2021-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 3,500 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,500 STERIS common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:40 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 1,900 | $88.00 | $167,200.00 |
DisclosureSEC source: 0001209191-17-060914 · doc4.xml · nonDerivative · entry 4 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,846 F3 · balance_after: 17,752 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,252 on May 30, 2018; 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020 and 6,000 on June 1, 2021. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:40 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 1,900 | $29.94 | $56,886.00 |
DisclosureSEC source: 0001209191-17-060914 · doc4.xml · nonDerivative · entry 3 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This exercise and sale of a total of 1,900 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 15, 2017. Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:40 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 1,750 | $88.00 | $154,000.00 |
DisclosureSEC source: 0001209191-17-060914 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,846 Read SEC document |
| November 14, 2017 Filed Nov 15, 2017 21:40 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 1,750 | $36.09 | $63,157.50 |
DisclosureSEC source: 0001209191-17-060914 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 1,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 15, 2017. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,900 | $0.00 Strike: $29.94 | $0.00 |
DisclosureSEC source: 0001209191-17-037327 · doc4.xml · derivative · entry 6 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Underlying: Ordinary Shares · 1,900 shares Expires 2022-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 3,800 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,800 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $31.87 | $0.00 |
DisclosureSEC source: 0001209191-17-037327 · doc4.xml · derivative · entry 5 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,000 shares Expires 2020-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 3,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,000 STERIS common shares for $31.87 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 1,900 | $78.00 | $148,200.00 |
DisclosureSEC source: 0001209191-17-037327 · doc4.xml · nonDerivative · entry 4 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,846 F3 · balance_after: 17,752 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,252 on May 30, 2018; 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020 and 6,000 on June 1, 2021. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 1,900 | $29.94 | $56,886.00 |
DisclosureSEC source: 0001209191-17-037327 · doc4.xml · nonDerivative · entry 3 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This exercise and sale of a total of 1,900 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on September 1, 2016. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 3,000 | $78.00 | $234,000.00 |
DisclosureSEC source: 0001209191-17-037327 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,846 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 3,000 | $31.87 | $95,610.00 |
DisclosureSEC source: 0001209191-17-037327 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 3,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on September 1, 2016. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 20:48 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 1,643 | $77.56 | $127,431.08 |
DisclosureSEC source: 0001209191-17-036821 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,846 F2 · shares: 1,643 shares were withheld from the 5,000 restricted shares that vested on May 31, 2017. These 1,643 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,000 ordinary shares were awarded to Mr. Zangerle on May 31, 2013. These vested shares were valued at the NYSE closing market price on May 31, 2017. F3 · balance_after: 17,752 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,252 on May 30, 2018; 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020 and 6,000 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 20:48 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-17-036821 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Ordinary Shares · 14,000 shares Expires 2027-05-30 F4 · derivative.exercise_date: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.